Nectar Lifesciences P/B Ratio
Nectar Lifesciences (NECLIFE) P/B ratio is 0.38 (Low), book value per share ₹306.32 vs Healthcare average P/B of -0.34 — Very Low - Significant discount to book value, potential distress or value opportunity. Compare with NECLIFE fundamental valuation to assess whether the stock is under or overvalued.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
NECLIFE P/B Ratio — Valuation Insights & Book Value Analysis
Nectar Lifesciences price-to-book ratio interpretation, valuation status and historical context — current P/B 0.38 (Low). For live price, earnings yield and the full fundamental profile, see NECLIFE share price screener.
- Stock appears undervalued with PB of 0.38, trading below book value
- Trading below book value - potential value opportunity or financial distress signal
- Current PB is 533.3% above historical average
- Trading at premium to sector average PB of -0.34
Nectar Lifesciences P/B Ratio Historical Trend
NECLIFE annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View NECLIFE annual price range for the annual high/low range and current price position.
NECLIFE Historical P/B Ratio — Book Value Per Share & Year-End Price
Nectar Lifesciences annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.05 | ₹306.32 | ₹14.36 | ₹582 | Low |
| 2025 | 0.05 | ₹434.55 | ₹20.90 | ₹956 | Low |
| 2024 | 0.08 | ₹485.91 | ₹39.00 | ₹1,069 | Low |
| 2023 | 0.07 | ₹484.09 | ₹32.16 | ₹1,065 | Low |
| 2022 | 0.05 | ₹494.55 | ₹24.45 | ₹1,088 | Low |
NECLIFE vs Healthcare Peers — P/B Ratio Comparison
Nectar Lifesciences P/B 0.38 vs Healthcare average -0.34, median 0.62 — range -18.41–1.12.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -3.86 | ₹27 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |